The inferred protein dependence coefficients indicated significantly higher dependence on FLT3 for tumors with FLT3-ITD mutation, a known proliferative driver in AML [30], consistent with the findings by Tyner et al. and in line with biological expectation (S4 Fig). This evidence concerns the gene FLT3 and acute myeloid leukemia.